Trinchieri Giorgio
Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA.
J Exp Med. 2007 Feb 19;204(2):239-43. doi: 10.1084/jem.20070104. Epub 2007 Feb 12.
Interleukin (IL)-10 is a cytokine that modulates both innate and adaptive immunity, primarily by exerting antiinflammatory effects. IL-10 was originally thought to be produced only by T helper (Th)2 cells, but is now known to be made by a variety of cell types. During many infections, CD4(+) T cells produce both interferon (IFN)-gamma, the signature Th1 cytokine, and IL-10. New data now show that the IL-10 produced by effector Th1 cells helps limit the collateral damage caused by exaggerated inflammation. But this control may also limit the effectiveness of the immune response, resulting in a failure to fully eliminate pathogens.
白细胞介素(IL)-10是一种主要通过发挥抗炎作用来调节固有免疫和适应性免疫的细胞因子。IL-10最初被认为仅由辅助性T(Th)2细胞产生,但现在已知多种细胞类型均可产生。在许多感染过程中,CD4(+) T细胞会同时产生标志性的Th1细胞因子干扰素(IFN)-γ和IL-10。新数据表明,效应性Th1细胞产生的IL-10有助于限制过度炎症引起的附带损害。但这种控制也可能会限制免疫反应的有效性,导致无法完全清除病原体。